Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 1P-LSD

Is 1P-LSD legal in Poland?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Controlled. Poland names this substance in its own national list. «1P-LSD» is entry lp. 44 in Załącznik nr 3, the list of new psychoactive substances. A Załącznik nr 3 entry is a new psychoactive substance within article 4 pkt 11a, a category defined as lying outside both the narcotic and the psychotropic definitions. The consequence is that the possession provision for it is article 62b and not article 62, which is a materially lighter band than the one that governs LSD itself at group I-P.
Consequences if caught
Capital exposure: none. Poland has no death penalty, and the possession provision that governs a Załącznik nr 3 substance opens at a fine. Possession is an offence under article 62b(1) of the 2005 Act and the penalty there is a fine. Where the quantity is considerable, article 62b(2) provides for a fine, a restriction of liberty or up to three years. Article 62b(3) lets proceedings be discontinued on the same insignificant quantity and own use test that article 62a applies to narcotics and psychotropics, again as a power and not an entitlement. The separate and lighter possession band is the practical consequence of sitting on Załącznik nr 3 rather than on Załącznik nr 1 or nr 2. Poland reaches the wider lysergamide field on the same annex as well, with ETH-LAD at lp. 36 and 1cP-LSD at lp. 54, so a substitution away from 1P-LSD does not reliably leave the list. Supply offences sit apart from possession. Article 56 punishes putting such a substance on the market with a fine and six months to eight years, and article 56(3) raises that to a fine and two years to twelve years where the quantity is considerable. Article 59(1) punishes supply for gain with one year to ten years.
If prescribed or medical
There is no authorised medicinal product with this substance in Poland, so no prescription route exists for it. The research-only confinement that article 33(2) puts on group I-P does not apply here, because this entry sits on the third annex rather than the first.
Documentation
No personal import route exists, because a listed substance may be brought in only under the licensing chapter of the 2005 Act and not on a traveller's own account. The certificate issued under article 75 of the Convention implementing the Schengen Agreement is the route for a prescribed controlled medicine and does not reach a substance for which no prescription can be written. Blotter and liquid presentations are seized on the same footing as any listed material, the difference being that the possession charge is the article 62b fine rather than the article 62 band that LSD itself attracts.
Primary sources
  • Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, tekst jednolity Dz.U. 2024 poz. 1139
  • api.sejm.gov.pl
  • Rozporządzenie Ministra Zdrowia z dnia 30 kwietnia 2025 r. zmieniające to rozporządzenie, Dz.U. 2025 poz. 598, w mocy od 22 maja 2025 r.
  • api.sejm.gov.pl
  • Rozporządzenie Ministra Zdrowia z dnia 7 lipca 2026 r. zmieniające to rozporządzenie, Dz.U. 2026 poz. 934, w mocy od 28 lipca 2026 r.
  • api.sejm.gov.pl
  • Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, tekst jednolity Dz.U. 2023 poz. 1939, art. 4 pkt 25 i 26, art. 31, art. 32, art. 33, art. 44f, art. 62, art. 62a, art. 62b
  • api.sejm.gov.pl
  • the regulation, both amending regulations and the Act were read at api.sejm.gov.pl on 21 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

1P-LSD in related jurisdictions

Other substances confirmed in Poland